Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection
Top Cited Papers
Open Access
- 15 November 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (10) , 3366-3369
- https://doi.org/10.1182/blood-2005-03-1100
Abstract
Natural killer (NK) cells are critical in the first-line defense against viral infections. Chronic HIV-1 infection leads to a perturbation in the NKKeywords
This publication has 19 references indexed in Scilit:
- Characterization of CD56–/CD16+natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individualsProceedings of the National Academy of Sciences, 2005
- Increased Natural Killer Cell Activity in Viremic HIV-1 InfectionThe Journal of Immunology, 2004
- CD107a as a functional marker for the identification of natural killer cell activityJournal of Immunological Methods, 2004
- Loss of HIV-1–specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1–specific CD4+ T CellsThe Journal of Experimental Medicine, 2004
- Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlatesProceedings of the National Academy of Sciences, 2003
- Nonpathogenic SIV Infection of Sooty Mangabeys Is Characterized by Limited Bystander Immunopathology Despite Chronic High-Level ViremiaImmunity, 2003
- Sustained Impairment of IFN-γ Secretion in Suppressed HIV-Infected Patients Despite Mature NK Cell Recovery: Evidence for a Defective Reconstitution of Innate ImmunityThe Journal of Immunology, 2002
- Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10AIDS, 2002
- HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individualsProceedings of the National Academy of Sciences, 2001
- Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.Journal of Clinical Investigation, 1998